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Abstract This study examines chromaff'm cell expression of the 
synaptosomal-associated protein SNAP-25 in the adrenal 
medulla by immunoblotting, immunocytochemistry and PCR. 
Both mRNAs coding for the SNAP-25 isoforms a and b were 
detected and SNAP-25 was found to be present in all chromaffin 
cells in adult rat adrenal gland sections. It was essentially 
restricted to a zone close to the cytoplasmic face of the plasma 
membrane in the majority of cells, but located extensively 
throughout the cytoplasm in a ehromaff'm cell sub-population, 
identified by double immunofluorescence labelling to have a 
noradrenergic phenotype. This differential SNAP-25 expression 
may reflect different stages in the phenotypic development of the 
sympathoadrenal lineage and be related to an additional 
functional role in noradrenergic hromaff'm cells not associated 
with secretion. 
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1. Introduction 
Neurones transport their secretory vesicles to their terminal 
cell surface where they are docked before releasing the con- 
tents into the extracellular space, in response to specific hem- 
ical or electrical stimuli in a regulated manner [1]. It has been 
suggested that N-ethylmaleimide sensitive fusion protein 
(NSF) and a number of soluble NSF attachment proteins 
(SNAPs) together constitute the neurotransmitter vesicle 
docking release apparatus and that the NSF-SNAP complex 
forms a bridge between SNAP receptors (SNAREs) in vesicu- 
lar and target membranes [2,3], although the exact function of 
NSF in the fusion process has recently been questioned [4]. 
The fusion complex includes at least three SNAREs, including 
SNAP-25 (synaptosomal-associated protein of 25 kDa) 
thought to act as one of the target SNAREs on the plasma 
membrane [5-7]. The central role of SNAP-25 in the exocy- 
tosis step of neurotransmission was first suggested by studies 
on the action on nerve terminals of certain bacterial neuro- 
toxins, for which it is a specific substrate [8-13]. Apart from 
its putative role in secretory mechanisms however, SNAP-25 
in neurones has also been suggested to be implicated in pro- 
cesses associated with cell plasticity, in particular those con- 
cerned with neurite growth [14-16]. 
In contrast o neurones, relatively few data are currently 
available on the potential role of SNAP-25 in neuroendocrine 
cells, in particular adrenal medullary chromaffin ceils, which 
have been employed for many years as an experimental model 
to study regulated exocytosis [17]. Such cells transport heir 
neuromodulators in large secretory granules with dense cores, 
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but small clear vesicles imilar in appearance to classical sy- 
naptic vesicles are also present, although the precise function 
of such microvesicles in these cells remains to be elucidated 
[18]. SNAP-25 has been shown to be present in PC12 tumour 
cells derived from adrenal medulla [19] and its presence in 
cultured chromaffin cells was reported while the present study 
was in progress [20]. In addition a possible role of SNAP-25 in 
secretion in chromaffin cells has been proposed [21,22]. 
The present study aimed to shed light on the likely function 
of SNAP-25 in neuroendocrine cells, given their ambiguity 
regarding the presence of both large dense core secretory 
granules and more classical small synaptic type vesicles. 
SNAP-25 and its corresponding mRNA was detected in the 
rat adrenal gland, in cultured bovine chromaffin cells and in 
PC12 cells by immunoblots and reverse transcriptase polymer- 
ase chain reaction (RT-PCR). Its cellular localisation in chro- 
maffin cells within the adrenal gland in situ, and in culture, 
was determined by both immunofluorescence and immunoper- 
oxidase cytochemistry with a monoclonal antibody [23] and 
compared with the distribution of the granule membrane mar- 
ker, dopamine [~-hydroxylase (DBH) by double immunofluo- 
rescence labelling to test whether SNAP-25 might be asso- 
ciated with secretory granules. SNAP-25 expression was also 
correlated with chromaffin cell phenotype, determined with 
antibodies against phenylethanolamine N-methyltransferase 
(PNMT), an enzyme characteristic of adrenergic ells. 
2. Materials and methods 
2.1. Antibodies 
Mouse monoclonal antibody SMI 81, originally produced by im- 
munising with rat hypothalamic tissue and previously named 02-29 
[23], was obtained from Sternberger Monoclonals Incorporated, Bal- 
timore, MD, USA. Rabbit polyclonal antibodies directed against a 
synthetic C-terminal SNAP-25 peptide [24] were generously supplied 
by Dr. M.C. Wilson (Scripps Institute, La Jolla, CA, USA). The rat 
polyclonal anti-DBH antibodies were those described previously [17]. 
Rabbit polyclonal anti-PNMT antibodies, generously donated by Dr. 
L. Denoroy (INSERM U 52, Lyon, France) were previously charac- 
terised on chromaffin cell cultures [25]. All secondary antibodies were 
affinity-purified and pre-adsorbed; tetramethyl rhodamine conjugated 
goat anti-mouse and donkey anti-rabbit IgGs, 5-{4,6-dichlorotriazin- 
2-yl} amino-fluorescein conjugated onkey anti-rabbit IgG and horse- 
radish peroxidase conjugated goat anti-mouse IgG were purchased 
from Euromedex (Strasbourg, France). Alkaline phosphatase conju- 
gated goat anti-mouse IgG and anti-rabbit IgG were from BioRad 
(Ivry sur Seine, France). 
2.2. Cell cultures 
Bovine chromaffin cells were isolated and plated for immunofluor- 
escence on collagen coated coverslips as previously described [25] and 
studied at 3-7 days of culture. The rat phaeochromocytoma PC12 cell 
line was purchased from ATCC (France) and grown in suspension i  
RPMI 1640 supplemented with 5% foetal calf serum and 10% horse 
serum (BRL-Gibco, Eragny, France). 
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2.3. Immunoprecipitation 
Rat cerebellar homogenates were solubilised in 'immunoprecipita- 
tion' buffer (50 mM Tris, 190 mM NaCI, 5 mM EDTA, 2.5% Triton 
X-100, 0.1% SDS, 2 mM phenylmethanesulphonyl fluoride pH 7.4). 
To reduce non-specific binding, the extract was first cleared by cen- 
trifugation and treated with protein A-Sepharose beads (BioRad) pre- 
incubated in non-immune serum. After a second centrifugation, the 
supernatant was incubated overnight at 4°C with protein A-Sepharose 
beads bound to SMI 81. Beads were subsequently washed in immu- 
noprecipitation buffer without detergent, before solubilising bound 
proteins for SDS-PAGE. 
2.4. Immunoblots 
Protein concentrations were determined by the Bradford method 
(BioRad). After SDS-PAGE, proteins were transferred onto nitrocel- 
lulose membranes (Hybond C-Extra, Amersham, Les Ulis, France) 
and SNAP-25 was detected with either SMI 81 (1:1000) or the poly- 
clonal anti-SNAP-25 antibodies (1:1000). Blots were then incubated 
with appropriate secondary antibodies conjugated to alkaline phos- 
phatase (1:1500) and developed with nitroblue tetrazolium-sodium 
salt and 5-bromo-4-chloro-3-indolyl phosphate (Sigma, Saint Quentin 
Fallavier, France). 
2.5. Analysis of SNAP-25 mRNA by RT-PCR 
Amplification of DNA complementary to SNAP-25 mRNA was 
performed firstly using oligonucleotide primers with sequences com- 
mon to both forms; the 5' primer (nucleotides 171-191) was on exon 
2 and the 3' primer (nucleotides 759-739) was on exon 8 (EMBL 
X51673). To distinguish between the messengers coding for the two 
isoforms, a and b, produced by alternative splicing of exon 5 [26], the 
common 3' primer was replaced by the 3' primer 5a corresponding to
nucleotides 295-262 (exon 5a, Genebank L19760) or 3' primer 5b 
corresponding to nucleotides 370-337 (exon 5b, EMBL X51673). 
The reverse transcription step was performed on total RNA with 
oligo-dT using a first strand synthesis kit (BRL-Gibco). For amplifi- 
cation, cDNA corresponding to 50 ng of total RNA was used. dNTP 
was from Boehringer Mannheim (France) and Taq polymerase and 
reaction buffer was from Appligene (Strasbourg, France) and 30 cy- 
cles were employed. Aliquots (10 ~1) of each PCR were run in parallel 
on 2% agarose gels. The common PCR product was characterised by 
restriction endonuclease digestion with Pstl, HindlII, SmaI (Boehrin- 
ger Mannheim, France). Sizes of products obtained were compared to 
those predicted by the cDNA sequence [24]. 
2.6. Immunoeytochemistry 
Cell cultures were fixed in phosphate buffered formaldehyde (4%, 
0.12 M, pH 7.2, 30 rain) and permeabilised in the same solution 
containing Triton X-100 (0.2%, 10 rain) before immunolabelling [27] 
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of the immunoprecipitate obtained with Fig. 1. (A) Immunoblots 
monoclonal antibody SMI 81 from rat cerebellum. Lane (a) detected 
with SMI 81, lane (b) the same immunoprecipitate d tected with 
rabbit anti-SNAP-25 polyclonal antibody. Both antibodies detect a 
single band migrating identically, with an apparent molecular mass 
of 25 kDa. (B) Immunoblot of soluble protein fractions of rat adre- 
nals (a), PC12 cells (b), bovine chromaffin cells (c) and rat cerebel- 
lum (d), detected with SMI 81. Molecular weights (kDa) are indi- 
cated on the left. 
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Fig. 2. RT-PCR amplification of SNAP-25 mRNA: ethidium bro- 
mide stained gels of the PCR products obtained from (a) rat adre- 
nal, (b) bovine chromaffin cells, (c) PC12 cells, (d) rat cerebellum, 
using the common 3' primer (exon 8) for the 591 bp SNAP-25 se- 
quence (first lane for each tissue) and the specific 3' primers for 
exon 5a or 5b for the 201 bp SNAP-25 a and b isoform sequences 
(second lane for each tissue isoform a, third lane isoform b). On the 
left, the 600 bp band in the 100 bp molecular weight ladder is more 
intense than the other bands. 
with SMI 81 (1:1000). Some cultures were also double labelled for 
SNAP-25 (SMI 81, 1:1000) and the granule marker DBH (1:500) 
after stimulation for 10 rain with 10 ~tM nicotine or 59 mM KC1 
[17] and fixation. For adrenal glands, adult Wistar rats were perfusion 
fixed, under anaesthesia, with the same fixative (without detergent, 
2 h); vibratome or cryostat sections were cut and labelled as pre- 
viously described [27]. For immunoperoxidase labelling, endogenous 
peroxidase activity was quenched by pretreatment with hydrogen per- 
oxide (0.1% in phosphate buffered saline, 10 min). 
2. 7. Confocal microscopy 
Serial optical sections (0.2 lam thick) of cultures were examined 
from approximately the central plane of the cell. Images were ac- 
quired using a Zeiss LSM 410 inverted laser scan confocal microscope 
using the 543 nm He/Ne laser as excitation source for rhodamine and 
488 nm argon laser for fluorescein. Emission signals were filtered with 
a Zeiss 515-565 nm filter (fluorescein) or with a 595 nm filter (rhoda- 
mine). Images were recorded igitally, stored and later down-loaded 
to a FOCUS digital image recorder. 
3. Results and discussion 
3.1. SNAP-25 in the adrenal gland 
The monoclonal antibody used here, produced several years 
ago using rat hypothalamic tissue as immunogen [23], has 
long been considered, from its cerebellar staining pattern, to 
recognise a synapse-associated antigen. Its specificity was first 
verified here by immunoprecipitation experiments on rat cer- 
ebellar homogenates. SMI 81 detected on immunoblots of 
electrophoresed samples prepared by immunoprecipitation 
with this antibody a single 25 kDa protein. An identical 
band was recognised in the same preparations by previously 
characterised [24] polyclonal anti-SNAP-25 peptide antibodies 
(Fig. 1A). Thus SMI 81 immunoprecipitates a protein, identi- 
fied as SNAP-25, that runs as a single band on SDS-PAGE. 
In addition, immunoblots with SMI 81 of cerebellar extracts 
were identical to those obtained with polyclonal anti-SNAP- 
25 antibodies and SMI 81 detected no bands on immunoblots 
of heart, lung and spleen extracts (as would be expected of 
tissues where SNAP-25 is absent; data not shown). Moreover 
the immunocytochemical l belling of rat cerebellum with SMI 
81 was the same as that reported for SNAP-25 (data not 
shown). SMI 81 was therefore considered here to be a specific 
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Fig. 3. Laser confocal microscope images of single optical sections 
of unstimulated (a,b) or K + stimulated chromaftin cells (c,d), fixed 
before immunofluorescence labelling for SNAP-25 with SMI 81 (a,c) 
or DBH (b,d). SNAP-25 labelling is peripheral, DBH labelling is cy- 
toplasmic. Bar = 5 ~tm. 
anti-SNAP-25 antibody, in agreement with the conclusions 
from other laboratories [28,29]. 
Immunoblotting with SMI 81 demonstrated SNAP-25 ex- 
pression in rat adrenal gland (Fig. 1B) and also confirmed, 
using a different antibody than employed elsewhere, its pres- 
ence in PC12 and cultured chromaffin cells, as recently re- 
ported [19,20]. Its electrophoretic migration was identical to 
that of the band detected in cerebellar extracts (lane d; Fig. 
1B), suggesting the likely conservation of its primary structure 
and antigenicity. 
A RT-PCR product with the size predicted from the SNAP- 
25 sequence (591 bp) was obtained from extracts of rat adre- 
nal gland, chromaffin cells, PC12 cells and rat cerebellum 
using the SNAP-25 primers common to both isoforms (Fig. 
2). Endonuclease digestion of this PCR product with PstI, 
HindlII and SmaI produced the digestion products predicted 
from the reported sequence [24]: 310 and 280 bp with HindlII 
and approximately 490 and 400 bp for the larger fragments 
obtained with PstI and SmaI respectively (data not shown). 
These data confirmed that the product amplified from these 
extracts was indeed from SNAP-25 mRNA. When sequence- 
specific 3' primers for either SNAP-25 a or b isoforms were 
employed, PCR products of the expected size (201 bp) were 
obtained from each tissue extract (Fig. 2), but the relative 
proportions of each appeared to vary. In contrast to the adre- 
nal tissues, the SNAP-25 isoform b was particularly predomi- 
nant in the cerebellum, providing further evidence that the 
major brain form is SNAP-25 [16,26]. 
3.2. ImmunocTtochemistry of SNAP-25 in adrenal chromaffin 
cells 
Immunofluorescence of cultured bovine chromaffin cells for 
SNAP-25 (Fig. 3a) demonstrated that it was located mainly in 
a region close to the surface membrane; very little cytoplasmic 
labelling was observed. However, it did not appear to be uni- 
Fig. 4. Bright field micrograpbs of vibratome (a,b) or cryostat (c) 
rat adrenal gland sections, immunoperoxidase (a,b) or immunofluo- 
rescence (c) labelled for SNAP-25 with SMI 81. Cortical cells (CO) 
are unstained; most medullary chromaffin cells are just surface la- 
belled, but cytoplasmic labelling is seen in cells in more intensely 
stained groups (b). Nerve fibres (arrow) and nerve terminals (arrow- 
heads) are heavily stained. An identical abelling pattern was ob- 
tained with the immunofluorescence technique (c). Bar = 40 ~tm for 
(a), 20 I.tm for (b) and (c). 
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formly distributed around the cell periphery and differences in 
labelling intensity between different cells or groups of cells 
were also evident. A similar pattern, particularly evident in 
approximately 1 gm thick epoxy resin embedded sections, was 
obtained with the immunoperoxidase method (data not 
shown). This contrasted with the more extensive cytoplasmic 
staining obtained for the secretory granule marker DBH (Fig. 
3b). When cells were stimulated with either nicotine or potas- 
sium before fixation and immunolabelling, no obvious 
changes in labelling patterns for either SNAP-25 (Fig. 3c) or 
DBH (Fig. 3d) compared to controls were observed. Thus no 
general colocalisation of these two proteins was evident in 
resting or stimulated cells. It may be concluded that SNAP- 
25 is not apparently associated at detectable vels with secre- 
tory granules distributed throughout the cytoplasm. 
In adrenal gland sections, nerve terminals and nerve fibre 
bundles were, as expected, intensely labelled for SNAP-25 by 
the immunoperoxidase m thod (Fig. 4a,b), but an unexpected 
staining pattern of chromaffin cells was found. Two sorts of 
cell groups could be distinguished by their SNAP-25 labelling. 
Cells in most groups had only peripheral staining, while cells 
in some groups, often located more peripherally in the medul- 
la, were stained throughout their cytoplasm (Fig. 4a,b). An 
identical differential SNAP-25 staining pattern between 
groups of chromaffin cells was also detected by immunofluo- 
rescence on either cryostat (Fig. 4c) or vibratome sections, 
excluding the possibility that such differential staining repre- 
sents an artefact either due to diffusion of peroxidase reaction 
product or due to the sectioning method employed. 
3.3. SNAP-25 expression and chromaffin cell phenotype 
The phenotype of chromaffin cells with cytoplasmic SNAP- 
25 staining was identified by double immunofluorescence la- 
belling with anti-PNMT antibodies, which label only adrener- 
gic cells [25]. The chromaffin cells with cytoplasmic labelling 
for SNAP-25 were found to be unlabelled with anti-PNMT 
antibodies (Fig. 5), leading to the conclusion that chromaffin 
cells with SNAP-25 distributed throughout heir cytoplasm 
are noradrenergic and those with only membrane-associated 
labelling are adrenergic. This novel finding that SNAP-25 dis- 
tribution and level of expression is dependent on chromaffin 
cell phenotype correlates with our present data showing 
SNAP-25 apparently only in a sub-plasmalemmal location 
in cultures of bovine chromatfin cells, since these consist 
mainly of adrenergic ells [25]. In another study, published 
while this work was in progress [20], also no differential stain- 
ing pattern in such cultures was reported. 
The cytoplasmic localisation found in noradrenergic cells 
was unexpected, since it has been described as essentially as- 
sociated with membranes [30], even though we found SNAP- 
25 to have a cytoplasmic distribution in rat cerebellar granule 
cells (unpublished data). It is thought o anchor to membranes 
by palmitoylation of clustered cysteine residues in a sequence 
that varies between the two isoforms [26]. While it is likely 
that the monoclonal antibody employed here recognises an 
epitope present in both isoforms, the localisation we found 
in adrenergic chromaffin cells is that of a plasma membrane- 
associated protein, probably SNAP-25b [26]. In the present 
study RT-PCR clearly demonstrated the presence of messen- 
ger coding for both isoforms in adrenal gland, PC12 and 
chromaffin cell culture extracts (Fig. 2). Palmitoylation of 
the SNAP-25 is considered to be a dynamic event, regulating 
R. Kannan et al./FEBS Letters 385 (1996) 159-164 
Fig. 5. Cryostat section of rat adrenal gland, double immunofluores- 
cence labelled for SNAP-25 with SMI 81 (a) and PNMT (b); phase 
contrast optics (c). Cells with intensely immunofluorescent cyto- 
plasm in (a) are unlabelled for PNMT (i.e. noradrenergic, NA) 
while in adrenergic (A), PNMT-positive chromaffin cells SNAP-25 
labelling is confined to the cell periphery. V indicates a blood vessel. 
Bar = 20 gm. 
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the extent of the attachment of the protein to the cell mem- 
brane. It thus seems likely that the SNAP-25 widely distrib- 
uted throughout he cytoplasm of noradrenergic cells lacks 
this post-translational modification, and may be the SNAP- 
25a isoform, which associates less readily with membranes 
[16,26]. 
3.4. SNAP-25 and function 
SNAP-25 is currently considered to be a receptor protein on 
the plasma membrane permitting synaptic vesicle docking be- 
fore membrane fusion [7,31]. Whether SNAP-25 performs a 
similar role in the secretion of chromaffin granules has yet to 
be proved, but the results reported here clearly demonstrate 
for the first time that SNAP-25 is present in these cells in situ, 
and establish that in adrenergic chromaffin cells it is limited to 
a region close to the cytoplasmic face of the plasma mem- 
brane, a localisation compatible with its putative function as 
a plasma membrane-associated SNARE. The apparent ab- 
sence of SNAP-25 on un-docked secretory granules of these 
cells, i.e. those distributed throughout the cytoplasm, demon- 
strated here by double labelling with a granule marker (Fig. 
3), also fits with such a role in granule docking. 
While at the present ime, reasons for the unexpected differ- 
ential SNAP-25 expression between the two major chromaffin 
cell phenotypes are not clear, the cytoplasmic localisation in 
noradrenergic cells may suggest hat in these cells SNAP-25 
could also be involved in processes other than regulated exo- 
cytosis, such as those associated with morphological plasticity, 
as has been previously proposed [14-16,32]. The subcellular 
localisation of SNAP-25 in neurones reported from several 
groups is not consistent with an exclusively exocytotic role 
for this protein [24,28,32,33]. Also in a parallel study we 
found at the ultrastructural level that splanchnic nerve term- 
inal synaptic vesicles in adrenal medulla were strongly labelled 
for SNAP-25, a localisation unexpected for a plasma mem- 
brane SNARE (unpublished ata). In this regard, it is inter- 
esting to note that the SNAP-25 isoform considered to be 
involved in morphological plasticity, a well documented phe- 
nomenon in noradrenergic hromaffin cells [34-36], is the 
more broadly distributed form [16] with modified palmitoyla- 
tion efficiency [26]. Expression of several other proteins has 
been found to differ between adrenergic and noradrenergic 
chromaffin cells in adult rat adrenal tissue. Two proteins 
also initially described as neurone-specific, the cell adhesion 
molecule L1 and the growth associated protein GAP-43 have 
both been found only in the noradrenergic chromaffin cell 
phenotype [27,37,38]. Moreover one of these, GAP-43, like 
SNAP-25, associates with membranes by palmitoylation [14] 
and its expression has been linked with cellular plasticity 
[34,39]. The expression of all these proteins may reflect the 
fact that noradrenergic chromaffin cells are phenotypically 
closer to neurones than adrenergic ells [40], which represent 
the terminal phenotype in this lineage, and supports the hy- 
pothesis that adrenergic and noradrenergic chromaffin cells 
represent two distinct lines within the sympathoadrenal line- 
age. 
Acknowledgements: We are indebted to Dr. M.C. Wilson for the gift 
of polyclonal antibodies against he synthetic C-terminal SNAP-25 
peptide, to Dr. L. Denoroy for the anti-PNMT antibodies, to Dr. 
S. Chasserot-Golaz for advice and practical help with the confocal 
laser microscopy and to D. Thiers~ for preparing the chromaffin cell 
cultures. 
References 
[1] De Camilli, P. and Jahn, R. (1990) Annu. Rev. Physiol. 52, 625- 
645. 
[2] Clary, D.O., Griff, I.C. and Rothman, J.E. (1990) Cell 61, 709- 
721. 
[3] Sollner, T. and Rothman, J.E. (1994) Trends Neurosci. 17, 344- 
348. 
[4] Morgan, A. and Burgoyne, R.D. (1995) Trends Cell Biol. 5, 335- 
337. 
[5] Martin, T.J.F. (1994) Curr. Opin. Neurobiol. 4, 626-632. 
[6] Sollner, T., Bennett, M.K., Whiteheart, S.W., Scheller, R.H. and 
Rothman, J.E. (1993) Cell 75, 409418. 
[7] Sudhof, T.C., De Camilli, P., Niemann, H. and Jahn, R. (1993) 
Cell 75, 14. 
[8] Binz, T., Blasi, J., Yamasaki, S., Baumeister, A., Link, E., Sud- 
hof, T.C., Jahn, R. and Niemann, H.J (1994) Biol. Chem. 269, 
1617-1620. 
[9] Blasi, J., Chapman, E.R., Link, E., Binz, T., Yamasaki, S., De 
Camilli, P., Sudhof, T.C., Niemann, H. and Jahn, R. (1993) 
Nature 365, 160-163. 
[10] Niemann, H., Blasi, J. and Jahn, R. (1994) Trends Cell Biol. 4, 
179-185. 
[11] Schiavo, G., Rossetto, O., Catsicas, S., Polverino de Laureto, P., 
Dasgupta, B.R., Benfenati, F. and Montecucco, C. (1993) J. Biol. 
Chem. 268, 23784-23787. 
[12] Bennett, M.K. and Scheller, R.H. (1994) Annu. Rev. Biochem. 
63, 63 100. 
[13] Horikawa, H.P.M., Saisu, H., Ishizuka, T., Sekine, Y., Tsugita, 
A., Odani, S. and Abe, T. (1993) FEBS Lett. 330, 236-240. 
[14] Hess, D.T., Patterson, S.I., Smith, D.S. and Skene, J.H.P. (1993) 
Nature 366, 562-565. 
[15] Osen-Sand, A., Catsicas, M., Jones, K.A., Ayala, G., Knowles, 
J., Grenningloh, G. and Catsicas, S. (1993) Nature 364, 445- 
448. 
[16] Bark, I.C., Hahn, K.M., Ryabinin, A.E. and Wilson, M.J. (1995) 
Proc. Natl. Acad. Sci. USA 92, 1510-1514. 
[17] Aunis, D., Perrin, D. and Langley, O.K. (1987) in: Stimulus- 
Secretion Coupling in Chromaffin Cells (Rosenheck, K. and 
Lelkes, P.I., Eds.) Vol. 1. pp. 155-175. CRC Press, Boca Raton, 
FL. 
[18] Jahn, R. and De Camilli, P. (1991) in: Markers for Neural and 
Endocrine Cells, Molecular and Cell Biology Diagnostic Appli- 
cations (Gratzl, M. and Langley, K., Eds.), pp. 25-92. VCH, 
Weinheim. 
[19] Oyler, G.A., Polli, J.W., Higgins, G.A., Wilson, M.C. and 
Billingsley, M.L. (1992) Dev. Brain Res. 65, 133-146. 
[20] Roth, D. and Burgoyne, R.D. (1994) FEBS Lett. 351, 207 210. 
[21] Ahnert-Hilger, G. and Weller, U. (1993) Neuroscience 53, 547- 
552. 
[22] Bartels, F., Bergel, H., Bigalke, H., Frevert, J., Halpern, J. and 
Middlebrook, J. (1994) J. Biol. Chem. 269, 8122-8127. 
[23] Sternberger, L.A., Harwell, L.W. and Sternberger, N.H. (1982) 
Proc. Natl. Acad. Sci. USA 79, 1326-1330. 
[24] Oyler, G.A., Higgins, G.A., Hart, R.A., Battenberg, E., Billings- 
ley, M., Bloom, F.E. and Wilson, M.C. (1989) J. Cell. Biol. 109, 
3039-3052. 
[25] Moro, M.A., Garcia, A.G. and Langley, O.K. (1991) J. Neuro- 
chem. 57, 363-369. 
[26] Bark, I.C. (1993) J. Mol. Biol. 233, 67--76. 
[27] L6on, C., Grant, N., Aunis, D. and Langley, K. (1992) Eur. J. 
Neurosci. 4, 201 209. 
[28] Sadoul, K., Lang, J., Montecuco, C., Weller, U., Regazzi, R., 
Catsicas, S., Wollheim, C.B. and Halbam P.A. (1995) J. Cell 
Biol. 128, 1019-1028. 
[29] Grabs, D., Bergmann, M., Urban, M., Post, A. and Gratzl, M. 
(1996) Eur. J. Neurosci. 8, 162 168. 
[30] Garcia, E.P., McPherson, P.S., Chilcote, T.J., Takei, K. and De 
Camilli, P. (1995) J. Cell Biol. 129, 105-120. 
[31] O'Connor, V., Augustine, G.T. and Betz, H. (1994) Cell 76, 785- 
787. 
[32] Oyler, G.A., Polli, J.W., Wilson, M.C. and Billingsley, M.L. 
(1991) Proc. Natl. Acad. Sci. USA 88, 5247 5251. 
[33] Catsicas, S., Catsicas, M., Keyser, K.T., Karten, H.J., Wilson, 
M.C. and Milner, R.J. (1992) J. Neurosci. Res. 33, 1~. 
164 R. Kannan et al./FEBS Letters 385 (1996) 159-164 
[34] Lin, L.-H., Bock, S., Carpenter, K., Rose, M. and Norden, J.J. 
(1992) Mol. Brain Res. 14, 147-153. 
[35] Greene, L.A. and Tischler, A.S. (1976) Proc. Natl. Acad. Sci. 
USA 73, 2424-2428. 
[36] Unsicker, K., Seidl, K. and Hofmann, H.D. (1989) Int. J. Dev. 
Neurosci. 7, 413417. 
[37] Langley, K. and Grant, N.J. (1995) Trends Neurosci. 18, 440. 
[38] Grant, N.J., Konig, F., Deloulme, J.-C., Aunis, D. and Langley, 
K. (1992) Eur. J. Neurosci. 4, 1257-1263. 
[39] Neve, R.L., Finch, E.A., Bird, E.D. and Benowitz, L.I. (1988) 
Proc. Natl. Acad. Sci. USA 85, 3638-3642. 
[40] Langley, K. (1994) Ann. NY Acad. Sci. 733, 1-17. 
